IDiyas

For the Inventor, By the Inventor

Lörrach, Germany

Volker Seibert

USPTO Granted Patents = 14 

Average Co-Inventor Count = 8.2

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal12 out of 52 
 
Agenus Inc.
 patents
silverMedal12 out of 559 
 
Memorial Sloan Kettering Cancer Center
 patents
bronzeMedal12 out of 525 
 
Ludwig Institute for Cancer Research Limited
 patents
4. 2 out of 4 
 
Mink Therapeutics, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2018-2024

Loading Chart...
14 patents (USPTO):Explore Patents
1. 11898165 - Engineered host cells and methods of use thereof (2024-02-13),
2. 11897962 - Anti-GITR antibodies and methods of use thereof (2024-02-13),
3. 11613764 - T cell receptors that bind to NY-ESO-1 and methods of use thereof (2023-03-28),
4. 11472883 - Methods of administering anti-OX40 antibodies (2022-10-18),
5. 11447557 - Antibodies and methods of use thereof (2022-09-20),
6. 11401335 - Anti-GITR antibodies and methods of use thereof (2022-08-02),
7. 11136404 - Anti-OX40 antibodies (2021-10-05),
8. 10836830 - Antibodies and methods of use thereof (2020-11-17),
9. 10829559 - Anti-GITR antibodies and methods of use thereof (2020-11-10),
10. 10800849 - Anti-GITR antibodies and methods of use thereof (2020-10-13),
11. 10626181 - Nucleic acids encoding anti-OX40 antibodies (2020-04-21),
12. 10577426 - Anti-GITR antibodies and methods of use thereof (2020-03-03),
13. 10280226 - Anti-GITR antibodies and methods of use thereof (2019-05-07),
14. 10155818 - Anti-GITR antibodies and methods of use thereof (2018-12-18),

Title: Unveiling the Innovative Mind of Volker Seibert

Introduction:

Volker Seibert, a prolific inventor hailing from Lörrach, Germany, has made significant strides in the field of biotechnology. With an impressive portfolio of 14 patents, his groundbreaking work has revolutionized the way we approach various medical challenges.

Latest Patents:

Seibert's recent patents showcase his ingenuity and commitment to advancing healthcare. One notable invention involves engineered host cells designed for the expression of functional T cell receptors (TCR), enabling the identification of TCRs that target specific peptide-major histocompatibility complex (MHC) complexes. Another patent focuses on the development of anti-GITR antibodies that hold promise in treating disorders like cancer and infectious diseases.

Career Highlights:

Throughout his career, Seibert has been associated with esteemed organizations such as Agenus Inc. and the Memorial Sloan Kettering Cancer Center. His tenure at these institutions has provided him with the platform to turn his innovative ideas into tangible solutions that benefit society.

Collaborations:

Seibert's collaborative spirit is evident in his work alongside colleagues like Taha Merghoub and David Schaer. Together, they have synergized their expertise to push the boundaries of scientific innovation and make meaningful contributions to the field of biotechnology.

Conclusion:

Volker Seibert's journey as an inventor has been marked by a relentless pursuit of excellence and a deep-seated passion for driving positive change through his inventions. His remarkable patents stand as a testament to his vision and commitment to shaping a better future through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…